Bavarian Nordic initiates Phase 3 study with chikungunya vaccine in children

The business’s injection Vimkunya is currently accepted for usage in individuals aged 12 years or older in the United States, EU and UK.

发布者:BY MARKETWIRE,转转请注明出处:https://robotalks.cn/bavarian-nordic-initiates-phase-3-study-with-chikungunya-vaccine-in-children/

(0)
上一篇 14 6 月, 2025 5:18 下午
下一篇 14 6 月, 2025 5:18 下午

相关推荐

发表回复

您的邮箱地址不会被公开。 必填项已用 * 标注

联系我们

400-800-8888

在线咨询: QQ交谈

邮件:admin@example.com

工作时间:周一至周五,9:30-18:30,节假日休息

关注微信
社群的价值在于通过分享与互动,让想法产生更多想法,创新激发更多创新。